Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
-
* Corresponding author: Carsten Denkert Carsten.Denkert@charite.de
Breast Cancer Research 2009, 11:R69 doi:10.1186/bcr2363
Accesses
- Last 30 days: 81 accesses
- Last 365 days: 1013 accesses
- All time: 5481 accesses